RUSSELL CORYELL: Open Payments
NPI 1366811721 · LAS CRUCES, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,035 in 49 payments from 13 companies in 2025. Trend: 2023 $903 · 2024 $1,083 · 2025 $1,035
Food & beverage: $1,035
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $387 |
| Viatris Specialty LLC | 8 | $164 |
| ABBVIE INC. | 11 | $147 |
| Lilly USA, LLC | 4 | $74 |
| Xeris Pharmaceuticals, Inc. | 3 | $66 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| Insulet Corporation | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| ABIOMED | 1 | $20 |
| BETA BIONICS, INC. | 1 | $19 |
Products named: FARXIGA, YUPELRI, AIRSUPRA, VRAYLAR, BREZTRI, GVOKE HYPOPEN, Sunosi, MOUNJARO.
Industry payments across NM — which companies pay providers there.
